프로바이오틱스 기반 영양보조식품 시장 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2025-2034년)

The Global Probiotics Based Dietary Supplement Market was valued at USD 8.4 billion in 2024 and is estimated to grow at a CAGR of 7.5% to reach USD 17.4 billion by 2034. These supplements, crafted with live strains like Lactobacillus, Bifidobacterium, and Saccharomyces, support digestive balance, bolster immunity, and enhance gut-brain health. Rising awareness around digestive wellness, preventive health, and allergen-free options is spurring demand. Today's consumers are opting for high-CFU, multi-strain formulations, as well as convenient formats like gummies and sachets. Broadening use among infants, seniors, and health-conscious adults-especially across North America and Asia-Pacific-is creating space for innovations in clinical validation, delivery systems, and clean-label offerings.

The shift toward dairy-free, transparency-focused products and sustainable sourcing reflects a wider trend in health-conscious and eco-minded nutrition, positioning probiotics as a central pillar of preventive wellness. Consumers are increasingly scrutinizing ingredient lists, demanding clean-label formulations that align with ethical values and dietary restrictions. This behavioral shift is accelerating the demand for plant-based and allergen-free probiotic supplements, pushing brands to innovate with non-dairy carriers, natural flavorings, and biodegradable packaging. As awareness grows around the gut's role in immunity, mood, and overall vitality, probiotics are no longer viewed as niche supplements but rather as daily essentials. This evolution is transforming how manufacturers approach product development, with traceability, environmental responsibility, and personalized health outcomes tailored to modern lifestyles.

The capsule segment dominated the market with a 35.7% share, totaling USD 3 billion in 2024. Their success is due to precise dosage, long shelf-life, and ease of use. Vegetarian, gelatin, and delayed-release versions cater to diverse consumer needs, ensuring probiotics survive stomach acid to reach the gut. High-CFU capsule options tailored for digestion, immunity, and mental health are particularly sought after amid growing interest in personalized gut health regimens.

Lactobacillus strains segment made up 30.4% share, worth USD 2.6 billion in 2024. These clinically backed strains-such as L.acidophilus, L.rhamnosus, and L.plantarum-are known for improving gut flora, strengthening immunity, and aiding lactose intolerance. Their resilience against stomach acid and adaptability in both single- and multi-strain blends make them popular in dairy-free and vegan probiotic products, especially prevalent in North American and Asian markets.

Asia-Pacific Probiotics Based Dietary Supplement Market held a 38.6% share in 2024. Growth in this region is driven by increasing digestive and immune health awareness, higher lactose intolerance rates, urbanization, and rising demand for functional foods. Local and international brands are expanding their retail presence and R&D to meet consumer needs, offering lactose-free, plant-based probiotic options. Government-led wellness campaigns, a growing middle class, and the regional popularity of fermented foods are contributing to mass adoption.

Key global innovators and distributors include Yakult Honsha Co., Ltd., BioGaia AB, Nestle S.A., Danone S.A., and Chr. Hansen Holding A/S. Leading firms are sharpening their competitive edge through strain diversification and transparent labeling, appealing to health-conscious and allergen-sensitive consumers. They're also investing in clinical trials to validate gut-brain, immune, and digestive health claims. Format innovation-with vegan capsules, delayed-release options, gummies, and powders-is broadening access across demographics. Companies are expanding e-commerce channels and direct-to-consumer models while forming partnerships with healthcare professionals and food brands to boost credibility.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product
  • 2.2.3 End Use
• 2.3 TAM Analysis, 2025-2034
• 2.4 CXO perspectives: Strategic imperatives
  • 2.4.1 Executive decision points
  • 2.4.2 Critical success factors
• 2.5 Future Outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier Landscape
  • 3.1.2 Profit Margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factor affecting the value chain
  • 3.1.5 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Industry pitfalls and challenges
  • 3.2.3 Market opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter's analysis
• 3.6 PESTEL analysis
  • 3.6.1 Technology and innovation landscape
  • 3.6.2 Current technological trends
  • 3.6.3 Emerging technologies
• 3.7 Price trends
  • 3.7.1 By region
  • 3.7.2 By product
• 3.8 Future market trends
• 3.9 Technology and innovation landscape
  • 3.9.1 Current technological trends
  • 3.9.2 Emerging technologies
• 3.10 Patent Landscape
• 3.11 Trade statistics (HS code) (Note: the trade statistics will be provided for key countries only)
  • 3.11.1 Major importing countries
  • 3.11.2 Major exporting countries
• 3.12 Sustainability and environmental aspects
  • 3.12.1 Sustainable practices
  • 3.12.2 Waste reduction strategies
  • 3.12.3 Energy efficiency in production
  • 3.12.4 Eco-friendly Initiatives

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 LATAM
    • 4.2.1.5 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Format, 2021 - 2034 (USD Million) (Kilo Tons)

• 5.1 Key trends
• 5.2 Capsules
  • 5.2.1 Vegetarian capsules
  • 5.2.2 Gelatin capsules
  • 5.2.3 Delayed-release capsules
  • 5.2.4 Others
• 5.3 Tablets
  • 5.3.1 Chewable tablets
  • 5.3.2 Enteric-coated tablets
  • 5.3.3 Others
• 5.4 Powders
  • 5.4.1 Single-serve sachets
  • 5.4.2 Bulk containers
  • 5.4.3 Others
• 5.5 Liquids
  • 5.5.1 Shots
  • 5.5.2 Drops
  • 5.5.3 Others
• 5.6 Gummies
  • 5.6.1 Gelatin-based
  • 5.6.2 Pectin-based
  • 5.6.3 Others
• 5.7 Others

Chapter 6 Market Estimates and Forecast, By Probiotic Strain, 2021 - 2034 (USD Million) (Kilo Tons)

• 6.1 Key trends
• 6.2 Lactobacillus
  • 6.2.1 L. acidophilus
  • 6.2.2 L. rhamnosus
  • 6.2.3 L. plantarum
  • 6.2.4 L. casei
  • 6.2.5 L. reuteri
  • 6.2.6 Others
• 6.3 Bifidobacterium
  • 6.3.1 B. bifidum
  • 6.3.2 B. longum
  • 6.3.3 B. lactis
  • 6.3.4 B. breve
  • 6.3.5 Others
• 6.4 Streptococcus
  • 6.4.1 S. thermophilus
  • 6.4.2 Others
• 6.5 Bacillus
  • 6.5.1 B. coagulans
  • 6.5.2 B. subtilis
  • 6.5.3 Others
• 6.6 Saccharomyces
  • 6.6.1 S. boulardii
  • 6.6.2 Others
• 6.7 Multi-strain formulations
• 6.8 Others

Chapter 7 Market Estimates and Forecast, By CFU Count, 2021 - 2034 (USD Million) (Kilo Tons)

• 7.1 Key trends
• 7.2 Below 1 billion CFU
• 7.3 1-10 billion CFU
• 7.4 10-50 billion CFU
• 7.5 Above 50 billion CFU

Chapter 8 Market Estimates and Forecast, By Consumer Demographics, 2021 - 2034 (USD Million) (Kilo Tons)

• 8.1 Key trends
• 8.2 Adults
  • 8.2.1 18-34 Years
  • 8.2.2 35-54 Years
  • 8.2.3 55+ Years
• 8.3 Children
  • 8.3.1 Infants (0-2 Years)
  • 8.3.2 Children (3-12 Years)
  • 8.3.3 Adolescents (13-17 Years)

Chapter 9 Market Estimates and Forecast, By Health Application, 2021 - 2034 (USD Million) (Kilo Tons)

• 9.1 Key trends
• 9.2 Digestive health
  • 9.2.1 Irritable bowel syndrome (IBS)
  • 9.2.2 Inflammatory bowel disease (IBD)
  • 9.2.3 Antibiotic-associated diarrhea
  • 9.2.4 Others
• 9.3 Immune health
• 9.4 Women's health
• 9.5 Weight management
• 9.6 Brain health
• 9.7 Oral health
• 9.8 Others

Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 (USD Million) (Kilo Tons)

• 10.1 Key trends
• 10.2 Retail pharmacies
• 10.3 Health & wellness stores
• 10.4 Supermarkets & hypermarkets
• 10.5 Online retail
  • 10.5.1 E-commerce platforms
  • 10.5.2 Brand websites
  • 10.5.3 Online pharmacies
• 10.6 Direct selling
• 10.7 Others

Chapter 11 Market Estimates and Forecast, By Region, 2021 - 2034 (USD Million) (Kilo Tons)

• 11.1 Key trends
• 11.2 North America
  • 11.2.1 U.S.
  • 11.2.2 Canada
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 France
  • 11.3.4 Spain
  • 11.3.5 Italy
  • 11.3.6 Netherlands
• 11.4 Asia Pacific
  • 11.4.1 China
  • 11.4.2 India
  • 11.4.3 Japan
  • 11.4.4 Australia
  • 11.4.5 South Korea
• 11.5 Latin America
  • 11.5.1 Brazil
  • 11.5.2 Mexico
  • 11.5.3 Argentina
• 11.6 Middle East and Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 South Africa
  • 11.6.3 UAE

Chapter 12 Company Profiles

• 12.1 Chr. Hansen Holding A/S
• 12.2 Danone S.A. (Activia, Actimel)
• 12.3 Yakult Honsha Co., Ltd.
• 12.4 Nestle S.A. (Garden of Life)
• 12.5 Probi AB
• 12.6 BioGaia AB
• 12.7 Probiotics International Ltd (Protexin)
• 12.8 Lallemand Inc.
• 12.9 DuPont (IFF)
• 12.10 Lifeway Foods, Inc.
• 12.11 Morinaga Milk Industry Co., Ltd.
• 12.12 Bifodan A/S
• 12.13 Culturelle (i-Health, Inc.)
• 12.14 Jarrow Formulas, Inc.
• 12.15 NOW Foods